Browse hierarchy: [Microbiology (MI)](/submissions/MI) → [Subpart D — Serological Reagents](/submissions/MI/subpart-d%E2%80%94serological-reagents) → [21 CFR 866.3350](/submissions/MI/subpart-d%E2%80%94serological-reagents/866.3350) → GRY — Antigens, All, Leptospira Spp.

# GRY · Antigens, All, Leptospira Spp.

_Microbiology · 21 CFR 866.3350 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/GRY

## Overview

- **Product Code:** GRY
- **Device Name:** Antigens, All, Leptospira Spp.
- **Regulation:** [21 CFR 866.3350](/submissions/MI/subpart-d%E2%80%94serological-reagents/866.3350)
- **Device Class:** 2
- **Review Panel:** [Microbiology](/submissions/MI)

## Identification

Leptospira spp. serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to Leptospira spp. in serum or identify Leptospira spp. from cultured isolates derived from clinical specimens. Additionally, some of these antisera are conjugated with a fluorescent dye (immunofluorescent reagents) and used to identify Leptospira spp. directly from clinical specimens. The identification aids in the diagnosis of leptospirosis caused by bacteria belonging to the genus Leptospira and provides epidemiological information on this disease. Leptospira infections range from mild fever-producing illnesses to severe liver and kidney involvement producing hemorrhage and dysfunction of these organs.

## Classification Rationale

Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 866.9.

## Special Controls

*Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 866.9.

## Recent Cleared Devices (2 of 2)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [K002024](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/GRY/K002024.md) | PANBIO INDX IGM DIP-S-TICKS LEPTOSPIROSIS TEST FOR THE DETECTION OF IGM ANTIBODIES TO LEPTOSPIRA BIFLEXA | Panbio, Inc. | Nov 22, 2000 | SESE |
| [K880417](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/GRY/K880417.md) | LEPTOSPIROSIS IHA | Hillcrest Biologicals | Apr 12, 1988 | SESE |

## Top Applicants

- Hillcrest Biologicals — 1 clearance
- Panbio, Inc. — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/GRY](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/GRY)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com